Gut Microbiota Dysbiosis in Diabetes: Mechanisms, Biomarkers, and Microbiome Targeted Interventions
SN Comprehensive Clinical Medicine · 06.08.2026 · 8 (1)
DOI: 10.1007/s42399-026-02577-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 06.08.2026. Verfasst von Arup Dey und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: Assam down town University, Guwahati, India.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus is a multifactorial metabolic disorder characterized by chronic hyperglycaemia, insulin resistance, and progressive systemic complications. Increasing evidence indicates that gut microbiota dysbiosis is associated with the initiation and progression of both type 1 and type 2 diabetes. Alterations in microbial composition, reduced diversity, depletion of beneficial commensals, and enrichment of opportunistic or pro-inflammatory taxa may contribute to impaired intestinal barrier integrity, metabolic endotoxemia, and chronic low-grade inflammation. These microbial shifts are associated with insulin resistance, hyperinsulinemia, and β-cell dysfunction through immune activation and disrupted host-microbe signalling. Beyond compositional shifts, diabetes is associated with profound functional alterations in microbial metabolism. Reduced production of protective metabolites such as short-chain fatty acids and dysregulated bile acid signalling co-exist with increased levels of detrimental metabolites, including branched-chain amino acids, lipopolysaccharide, trimethylamine-N-oxide, and imidazole propionate. Together, these changes Together, these changes are characteristic of a dysregulated microbial metabolic state that has been observed to correlate with disease progression. This review synthesises clinical, mechanistic, and translational evidence linking gut microbiota dysbiosis to diabetes. It highlights disease-specific microbial and metabolite signatures that remain investigational for diagnostic and prognostic potential and evaluates current therapeutic strategies targeting the microbiome, including diet, probiotics, prebiotics, synbiotics, and fecal microbiota transplantation. Collectively, the evidence highlights the gut microbiome as a potential factor in diabetic pathophysiology and a promising, though still investigational, target for precision-based interventions. Graphical Abstract
Förderung
- Assam down town University, Guwahati, India
Zitieren
APA
Dey, A., Bhattachrjee, A., Modak, K., Chakraborty, B., Gautam, M. K., & Mondal, S. (2026). Gut Microbiota Dysbiosis in Diabetes: Mechanisms, Biomarkers, and Microbiome Targeted Interventions. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02577-4
Vancouver
Dey A, Bhattachrjee A, Modak K, Chakraborty B, Gautam MK, Mondal S. Gut Microbiota Dysbiosis in Diabetes: Mechanisms, Biomarkers, and Microbiome Targeted Interventions. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02577-4
BibTeX
@article{Dey2026,
author = {Dey, Arup and Bhattachrjee, Arghadeep and Modak, Kaushik and Chakraborty, Binita and Gautam, Manish Kumar and Mondal, Sandip},
title = {Gut Microbiota Dysbiosis in Diabetes: Mechanisms, Biomarkers, and Microbiome Targeted Interventions},
journal = {SN Comprehensive Clinical Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.1007/s42399-026-02577-4}
}
EUVIMED